Pricing

Log inSign up

Eyenovia

0 followers

‌

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print platform technology.

Industries

Pharmaceutical

Headquarters

New York, United States

Employees

51-200

Links

Org chart

Sean Ianchulev
CEO, Chief Medical Officer, Director & Founder
Collapse
Lauren Gidden
AVP, Quality & Regulatory Affairs
DC
Daryn Caldwell
Director, Commercial Operations | Training & Development
Greg Bennett
VP of Clinical Program Strategy & Development
Bren Kern
COO
Julie Whitcomb
Head Of Medical Affairs - Sr. Director
Michael Rowe
COO

Board & advisors

Charles Mather
Director
Mark Bullimore
Scientific Advisor
Pamela Gallin
Scientific Advisor
James C. Tsai
Scientific Advisor
Robert N. Weinreb
Scientific Advisor
Francis Mah
Scientific Advisor
Jason Jones
Scientific Advisor
April Jasper
Scientific Advisor
Rachel Jacobson
Independent Director
Stephen Benjamin
Independent Director
Ram Palanki
Independent Director
Ellen Strahlman
Independent Director

Teams

+3

Scientific Advisors

7 people · 0 jobs

Leadership Team

3 people · 0 jobs

LG

Quality Assurance and Regulatory Affairs

2 people · 0 jobs

Research and Development

1 person · 0 jobs

Clinical Operations

2 people · 0 jobs

KG

Finance and Administration

3 people · 0 jobs

Offices

Similar companies

Xeris Pharmaceuticals

2 followers

Cosette Pharmaceuticals

1 follower

Bristol-Myers Squibb

250 followers

NYU Langone Health

24 followers

West Pharmaceutical Services

8 followers

Curia Global

6 followers

AbbVie

269 followers

Navitus Health

3 followers

Corcept Therapeutics

4 followers

Catalyst Pharmaceuticals

2 followers

Arthritis Knee Pain Centers

2 followers

Explore companies